Not yet recruitingNCT03569553

A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients

Studying Inhalational anthrax

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Emergent BioSolutions
Principal Investigator: Brandon Essink, MD, md
Intervention: AIGIV(drug)
Enrollment: 100 target
Eligibility: All sexes
Timeline: 2027 – 2027

Collaborators

Centers for Disease Control and Prevention · Department of Health and Human Services

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03569553 on ClinicalTrials.gov

← Back to all trials